Showing 1 - 7 results of 7 for search 'Poramed Winichakoon', query time: 0.02s
Refine Results
-
1
-
2
Diagnostic performance between in-house and commercial SARS-CoV-2 serological immunoassays including binding-specific antibody and surrogate virus neutralization test (sVNT) by Poramed Winichakoon, Jiraprapa Wipasa, Kriangkrai Chawansuntati, Parichat Salee, Tavitiya Sudjaritruk, Saowaluck Yasri, Chantana khamwan, Rungnapa Peerakam, Dararat Dankai, Romanee Chaiwarith
Published 2023-01-01
Article -
3
Comparison of Immunogenicity and Reactogenicity of Five Primary Series of COVID-19 Vaccine Regimens against Circulating SARS-CoV-2 Variants of Concern among Healthy Thai Population... by Tavitiya Sudjaritruk, Oramai Mueangmo, Jutamad Saheng, Poramed Winichakoon, Parichat Salee, Worawan Wongjak, Tanachot Chaito, Jutarat Praparattanapan, Khanuengnit Nuket, Nuttarika Solai, Jiraprapa Wipasa, Kriangkrai Chawansuntati, Romanee Chaiwarith
Published 2023-03-01
Article -
4
Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac<sup>®</sup> and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort S... by Phoom Narongkiatikhun, Kajohnsak Noppakun, Romanee Chaiwarith, Poramed Winichakoon, Surachet Vongsanim, Yuttitham Suteeka, Karn Pongsuwan, Prit Kusirisin, Nuttanun Wongsarikan, Kanda Fanhchaksai, Chantana Khamwan, Dararat Dankai, Vuddhidej Ophascharoensuk
Published 2023-03-01
Article -
5
Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac<sup>®</sup> and ChAdOx1 nCoV-19 among Hemodialysis Patients: An... by Phoom Narongkiatikhun, Kajohnsak Noppakun, Romanee Chaiwarith, Poramed Winichakoon, Surachet Vongsanim, Yuttitham Suteeka, Karn Pongsuwan, Prit Kusirisin, Nuttanun Wongsarikan, Kanda Fanhchaksai, Chantana Khamwan, Dararat Dankai, Vuddhidej Ophascharoensuk
Published 2023-09-01
Article -
6
Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine by Romanee Chaiwarith, Poramed Winichakoon, Parichat Salee, Tavitiya Sudjaritruk, Jiraprapa Wipasa, Kriangkrai Chawansuntati, Saowaluck Yasri, Harit Thongwitokomarn, Kawisara Krasaewes, Sethawut Ruangsirinusorn, Jutarat Praparattanapan, Nuttarika Solai, Khanuengnit Nuket, Darakorn Boonmee, Orapin Chaichana, Oramai Mueangmo, Jutamad Saheng, Worawan Wongjak
Published 2023-11-01
Article -
7
Immunogenicity and safety of heterologous versus homologous prime-boost schedules with inactivated and adenoviral vectored SARS-CoV-2 vaccines – A prospective multi-center study by Pawat Phuensan, Jarongkorn Sirimongkolkasem, Terapong Tantawichien, Jeerath Phannajit, Stephen J. Kerr, Pokrath Hansasuta, Prawat Chantharit, Adisorn Wongsa, Pusit Fuengfoo, Anutra Chittinandana, Kriengsak Vareesangthip, Methee Chayakulkeeree, Sureeporn Jangsirikul, Araya Schmidt, Kanyika Wanvimonsuk, Poramed Winichakoon, Rattagan Kajeekul, Wichai Prayoonwiwat, Rungsun Rerknimitr
Published 2024-01-01
Article